1. Academic Validation
  2. Pyrrolopyrimidines: An update on recent advancements in their medicinal attributes

Pyrrolopyrimidines: An update on recent advancements in their medicinal attributes

  • Eur J Med Chem. 2018 Sep 5:157:503-526. doi: 10.1016/j.ejmech.2018.08.023.
Shelly Pathania 1 Ravindra K Rawal 2
Affiliations

Affiliations

  • 1 Department of Pharmaceutical Chemistry, Indo-Soviet Friendship College of Pharmacy (ISFCP), Moga, 142001, India; Department of Pharmaceutical Sciences and Technology, Maharaja Ranjit Singh Punjab Technical University, Bathinda, 151001, Punjab, India.
  • 2 Department of Chemistry, Maharishi Markandeshwar (Deemed to be University), Mullana, 133207, Ambala, Haryana, India. Electronic address: [email protected].
Abstract

Fused heterocycles are reported to demonstrate variety of biological activities such as Anticancer, Antibacterial, Antifungal and anti-inflammatory, and are thus exhaustively utilized in the field of medicinal chemistry. Pyrrolopyrimidines is one of the major classes of fused heterocycles which are extensively reported throughout the literature. Several reports suggest that pyrrolopyrimidine as fused scaffold possess more diverse and potent pharmacological profile than individual pyrrole and pyrimidine nucleus. Different pathological targets require different structural attributes reflected via varied substitutions, thus in recent years, researchers have employed various synthetic strategies to achieve desired substitutions on the pyrrolopyrimidine nucleus. In this review, authors highlight the recent advancement in this area, special focus was laid on the pharmacological profile and structure-activity relationship studies (SAR) of various synthesized pyrrolopyrimidine derivatives.

Keywords

Anticancer; Antiviral; Medicinal attributes; Pyrrolopyrimidines; SAR studies.

Figures